Particle.news

Download on the App Store

UnitedHealth Leverages $3.3 Billion Private Equity Deals to Sustain Earnings Streak Ahead of Q2 Report

Buyback-clause transactions conceal mounting care expenses ahead of the July 29 earnings release.

Image
UnitedHealth stock is under duress as it made a surprising move to win over Wall Street.
Image
Image

Overview

  • UnitedHealth sold stakes in business units to Warburg Pincus and KKR late last year, generating $3.3 billion in profits to preserve its 60-quarter earnings-beat streak.
  • The transactions included repurchase obligations that require the insurer to buy back assets at higher prices, prompting questions over earnings engineering.
  • The company excluded a $7.1 billion loss from its Brazil exit when reporting adjusted operating income and earnings per share.
  • UnitedHealth’s stock has tumbled nearly 45% year-to-date as medical care ratios climbed and full-year profit guidance was suspended.
  • A Justice Department criminal investigation into Medicare Advantage coding practices heightens regulatory risk ahead of the July 29 second-quarter results.